News
Schrödinger’s Statement Regarding FDA Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs
Schrödinger, Inc. (Nasdaq: SDGR) strongly supports the U.S. Food and Drug Administration’s (FDA) plan to reduce, refine or potentially replace current animal testing requirements with new approaches designed to improve drug safety and accelerate the evaluation process,
The Physicians Committee for Responsible Medicine, a nonprofit that advocates for nonanimal science, is applauding the new ...
A new undercover investigation by Last Chance for Animals (LCA) has exposed the disturbing abuse and suffering rats endure in a North American toxicology ... the experiments continued with no ...
Appropriately monitored and regulated animal experiments have been and still are necessary ... laboratory animals are not used for Testing cosmetic ingredients Toxicology testing Statutory ...
Physicians Committee experts traveled to Orlando, Florida, to attend the Society of Toxicology Annual Meeting (SOT) as part of our work to accelerate the replacement of animal testing in toxicology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback